the Efficacy and Safety of CLAE in R/R T-ALL/LBL
NCT04679506 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2020-12-22
Summary
To evaluate the efficacy and safety of CLAE regimen (cladribine + cytarabine + etoposide) in the treatment of relapsed/refractory T-ALL/LBL.
Conditions
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Interventions
- DRUG
-
Cladribine
CLAE regimen (cladribine + cytarabine + etoposide) for reinduction of R/R T-ALL/LBL
Sponsors & Collaborators
-
Peking University Third Hospital
lead OTHER
Principal Investigators
-
Hongmei Jing, MD, phD · Peking University Third Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-31
- Primary Completion
- 2021-12-31
- Completion
- 2023-12-31
More Related Trials
-
Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia
NCT01279096 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study Investigating the Combination of Cladribine, Low Dose Cytarabine and Sorafenib Alternating With Decitabine in Pediatric Relapsed and Refractory Acute Leukemias
NCT06474663 ·Status: WITHDRAWN ·Phase: PHASE1
-
Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi Leukemia
NCT05870995 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT04825496 ·Status: UNKNOWN ·Phase: PHASE1
-
Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL
NCT05578378 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid Leukemia
NCT05330364 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of APG2575 Single Agent and Combination Therapy in Patients With Relapsed/Refractory CLL/SLL
NCT04494503 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia
NCT02544789 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma
NCT06434467 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for de Novo Acute Myeloid Leukemia
NCT05906914 ·Status: COMPLETED ·Phase: PHASE2
-
Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia
NCT01842672 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Lintuzumab-Ac225 in Combination with Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid Leukemia
NCT03441048 ·Status: COMPLETED ·Phase: PHASE1
-
Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL
NCT05147467 ·Status: RECRUITING ·Phase: PHASE2
-
A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
NCT01066494 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Elderly Chinese Acute Myeloid Leukemia Patients Aged 65 to 75 Years Old
NCT02432911 ·Status: UNKNOWN ·Phase: NA
-
A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia
NCT00930098 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL
NCT06481241 ·Status: RECRUITING ·Phase: NA
-
A Study of XY0206 Tablets in Patients With Relapsed / Refractory Acute Myeloid Leukemia
NCT04471064 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
NCT07074496 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .
NCT05959694 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)
NCT07053020 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
CAV Regimen for R/R Ph- B-ALL
NCT05657652 ·Status: RECRUITING ·Phase: NA
-
Lenalidomide in Combination With CHOP in Patients With Untreated PTCL
NCT04423926 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
NCT06054113 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Clinical Study of SHP674 (Pegaspargase) in Participants With Newly Diagnosed, Untreated Acute Lymphoblastic Leukemia
NCT04067518 ·Status: COMPLETED ·Phase: PHASE2